Skip to main content
. 2016 Feb 19;4:4. doi: 10.1186/s40364-016-0058-3

Fig. 1.

Fig. 1

Kaplan-Meier overall or recurrence-free survival estimates for seven early stage lung adenocarcinoma cohorts and the TCGA LUAD validation cohort [410, 16]. Each cohort was split according to ESLA-7 score (red: > median, black: ≤ median)